Related Experiment Video
Updated: Jun 19, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus
Kotaro Mitsutake1, Natsuki Shinya1, Masafumi Seki2
1Department of Infectious Diseases and Infection Control, Saitama International Medical Center, Saitama Medical University, 397-1, Hidaka, Saitama, 350-1298, Japan.
Background:
Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis.
Methods:
This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019.
Results:
A total of 65 patients from 19 centers were included, with a mean age of 67 years and 26 % were female. Fifty percent of the patients with IE were had nosocomial infections and 25 % had prosthetic valve involvement. The most common comorbidities were hemodialysis (20 %) and diabetes (20 %). Congestive heart failure was present in 86 % of patients (NYHA class I, II: 48 %; III, IV: 38 %). The 30-day and in-hospital mortality rates were 29 % and 46 %, respectively. Multi-organ failure was the primary cause of death, accounting for 43 % of all causes of death. Prognostic factors for in-hospital mortality were age, disseminated intravascular coagulation, daptomycin and/or linezolid as initial antibiotic therapy, and surgery. Surgical treatment was associated with a lower mortality rate (odds ratio [OR], 0.026; 95 % confidence interval [CI], 0.002-0.382; p = 0.008 for 30-day mortality and OR, 0.130; 95 % CI; 0.029-0.584; p = 0.008 for in-hospital mortality).
Conclusion:
Mortality due to MRSA-IE remains high. Surgical treatment is a significant prognostic predictor of MRSA-IE.
Insights
Methicillin-resistant Staphylococcus aureus infective endocarditis (MRSA-IE) has high mortality. Surgical treatment significantly improves prognosis for MRSA-IE patients, reducing mortality rates.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is a severe condition with high mortality rates.
- Understanding patient characteristics and prognostic factors in Japan is crucial for improving outcomes.
Purpose of the Study:
- To investigate the clinical features of patients diagnosed with MRSA-IE in Japan.
- To identify key factors influencing the prognosis of MRSA-IE.
Main Methods:
- A retrospective analysis of 65 patients diagnosed with MRSA-IE between January 2015 and April 2019.
- Data collected from 19 medical centers across Japan.
Main Results:
- The study included patients with a mean age of 67 years; 26% were female. Common factors included nosocomial infections (50%), prosthetic valve involvement (25%), hemodialysis (20%), and diabetes (20%). Congestive heart failure was prevalent in 86% of patients.
- In-hospital mortality was 46%, with multi-organ failure as the leading cause of death (43%). Prognostic factors for mortality included advanced age, disseminated intravascular coagulation, and initial antibiotic therapy with daptomycin and/or linezolid.
- Surgical treatment was associated with significantly lower 30-day mortality (OR, 0.026; P=.008) and in-hospital mortality (OR, 0.130; P=.008).
Conclusions:
- Mortality associated with MRSA-IE remains a significant clinical challenge.
- Surgical intervention emerges as a critical factor for improving survival in patients with MRSA-IE.
More Related Videos
09:03Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
Published on: September 5, 2013
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Clinical Significance of Antibiotic Resistance